Pharmadrug (TSE:PHRX) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
PharmaDrug Inc. is issuing $414,523 in debenture units to replace outstanding convertible debentures, providing investors an opportunity to convert them into common shares. The issuance includes 8,290,000 common share purchase warrants, enhancing investor incentive with the potential for share acquisition at a set price.
For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.